HEADER TRANSPORT PROTEIN 09-FEB-22 7TXT TITLE STRUCTURE OF HUMAN SEROTONIN TRANSPORTER BOUND TO SMALL MOLECULE '8090 TITLE 2 IN LIPID NANODISC AND NACL COMPND MOL_ID: 1; COMPND 2 MOLECULE: 15B8 FAB HEAVY CHAIN; COMPND 3 CHAIN: C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 15B8 FAB LIGHT CHAIN; COMPND 7 CHAIN: D; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: SODIUM-DEPENDENT SEROTONIN TRANSPORTER; COMPND 11 CHAIN: S; COMPND 12 SYNONYM: SERT,5HT TRANSPORTER,5HTT,SOLUTE CARRIER FAMILY 6 MEMBER 4; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_TAXID: 10090; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 8 ORGANISM_TAXID: 10090; SOURCE 9 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: SLC6A4, HTT, SERT; SOURCE 16 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS NEUROTRANSMITTER TRANSPORTER, SMALL MOLECULE, MEMBRANE PROTEIN, KEYWDS 2 TRANSPORT PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR I.SINGH,A.SETH,C.B.BILLESBOELLE,J.BRAZ,R.M.RODRIGUIZ,K.ROY,B.BEKELE, AUTHOR 2 V.CRAIK,X.P.HUANG,D.BOYTSOV,P.LAK,H.O'DONNELL,W.SANDTNER,B.L.ROTH, AUTHOR 3 A.I.BASBAUM,W.C.WETSEL,A.MANGLIK,B.K.SHOICHET,G.RUDNICK REVDAT 2 27-MAR-24 7TXT 1 JRNL REVDAT 1 15-MAR-23 7TXT 0 JRNL AUTH I.SINGH,A.SETH,C.B.BILLESBOLLE,J.BRAZ,R.M.RODRIGUIZ,K.ROY, JRNL AUTH 2 B.BEKELE,V.CRAIK,X.P.HUANG,D.BOYTSOV,V.M.POGORELOV,P.LAK, JRNL AUTH 3 H.O'DONNELL,W.SANDTNER,J.J.IRWIN,B.L.ROTH,A.I.BASBAUM, JRNL AUTH 4 W.C.WETSEL,A.MANGLIK,B.K.SHOICHET,G.RUDNICK JRNL TITL STRUCTURE-BASED DISCOVERY OF CONFORMATIONALLY SELECTIVE JRNL TITL 2 INHIBITORS OF THE SEROTONIN TRANSPORTER. JRNL REF CELL V. 186 2160 2023 JRNL REFN ISSN 1097-4172 JRNL PMID 37137306 JRNL DOI 10.1016/J.CELL.2023.04.010 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, SERIALEM, CRYOSPARC, REMARK 3 CRYOSPARC, CRYOSPARC, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.000 REMARK 3 NUMBER OF PARTICLES : 187696 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7TXT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-FEB-22. REMARK 100 THE DEPOSITION ID IS D_1000262641. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN SEROTONIN TRANSPORTER IN REMARK 245 COMPLEX WITH FAB15B8 BOUND TO ' REMARK 245 8090 IN NACL; SODIUM-DEPENDENT REMARK 245 SEROTONIN TRANSPORTER; FAB15B8 REMARK 245 HEAVY CHAIN; FAB15B8 LIGHT CHAIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2100.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, S REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN S 145 CG OD1 ND2 REMARK 470 LYS S 201 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HE ARG C 38 OE1 GLN C 101 1.54 REMARK 500 O ILE S 544 H PHE S 548 1.59 REMARK 500 O THR S 603 H ARG S 607 1.59 REMARK 500 O PRO S 571 OG SER S 574 2.06 REMARK 500 OE2 GLU S 444 OG1 THR S 448 2.09 REMARK 500 OH TYR S 289 OG1 THR S 371 2.13 REMARK 500 OH TYR S 385 OD1 ASN S 416 2.13 REMARK 500 NH1 ARG C 59 O GLU C 108 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA C 119 -146.84 45.39 REMARK 500 ALA D 108 -177.64 -172.28 REMARK 500 ILE S 154 -62.09 -123.23 REMARK 500 PHE S 213 55.37 -94.36 REMARK 500 LYS S 399 -107.93 59.08 REMARK 500 ALA S 401 -159.88 71.84 REMARK 500 THR S 497 31.33 -95.51 REMARK 500 SER S 559 85.26 -154.78 REMARK 500 GLN S 562 55.16 -91.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-26160 RELATED DB: EMDB REMARK 900 STRUCTURE OF HUMAN SEROTONIN TRANSPORTER BOUND TO SMALL MOLECULE ' REMARK 900 8090 IN LIPID NANODISC AND NACL DBREF 7TXT C 20 139 PDB 7TXT 7TXT 20 139 DBREF 7TXT D 21 131 PDB 7TXT 7TXT 21 131 DBREF 7TXT S 77 617 UNP P31645 SC6A4_HUMAN 77 617 SEQRES 1 C 120 GLN VAL GLN LEU GLN GLN SER GLY PRO GLU LEU VAL LYS SEQRES 2 C 120 LEU GLY ALA SER VAL ARG ILE SER CYS LYS ALA SER GLY SEQRES 3 C 120 TYR ARG PHE SER TYR SER TRP MET ASN TRP VAL LYS GLN SEQRES 4 C 120 ARG PRO GLY LYS GLY LEU GLU TRP ILE GLY ARG ILE TYR SEQRES 5 C 120 PRO GLY ASP GLY ASP THR LYS TYR SER GLY LYS PHE LYS SEQRES 6 C 120 GLY LYS ALA THR LEU THR ALA ASP LYS SER SER SER THR SEQRES 7 C 120 VAL TYR MET GLN LEU SER SER LEU THR SER GLU ASP SER SEQRES 8 C 120 ALA VAL TYR PHE CYS ALA ARG SER ALA TYR GLY SER GLU SEQRES 9 C 120 GLY PHE ALA MET ASP TYR TRP GLY GLN GLY THR SER VAL SEQRES 10 C 120 THR VAL SER SEQRES 1 D 111 ASP ILE VAL LEU THR GLN SER PRO ALA SER LEU ALA VAL SEQRES 2 D 111 SER LEU GLY GLN ARG ALA THR ILE SER CYS ARG ALA SER SEQRES 3 D 111 GLU SER VAL ASP ASN TYR GLY ILE SER PHE LEU ASN TRP SEQRES 4 D 111 PHE GLN GLN LYS PRO GLY GLN PRO PRO LYS LEU LEU ILE SEQRES 5 D 111 TYR ALA ALA SER ASN GLN GLY SER GLY VAL PRO ALA ARG SEQRES 6 D 111 PHE SER GLY SER GLY SER GLY THR TYR PHE SER LEU ASN SEQRES 7 D 111 ILE HIS PRO MET GLU GLU ASP ASP THR ALA VAL TYR PHE SEQRES 8 D 111 CYS GLN GLN THR LYS GLY VAL SER TRP THR PHE GLY GLY SEQRES 9 D 111 GLY THR LYS VAL GLU ILE LYS SEQRES 1 S 541 GLY GLU ARG GLU THR TRP GLY LYS LYS VAL ASP PHE LEU SEQRES 2 S 541 LEU SER VAL ILE GLY TYR ALA VAL ASP LEU GLY ASN VAL SEQRES 3 S 541 TRP ARG PHE PRO TYR ILE CYS TYR GLN ASN GLY GLY GLY SEQRES 4 S 541 ALA PHE LEU LEU PRO TYR THR ILE MET ALA ILE PHE GLY SEQRES 5 S 541 GLY ILE PRO LEU PHE TYR MET GLU LEU ALA LEU GLY GLN SEQRES 6 S 541 TYR HIS ARG ASN GLY CYS ILE SER ILE TRP ARG LYS ILE SEQRES 7 S 541 CYS PRO ILE PHE LYS GLY ILE GLY TYR ALA ILE CYS ILE SEQRES 8 S 541 ILE ALA PHE TYR ILE ALA SER TYR TYR ASN THR ILE MET SEQRES 9 S 541 ALA TRP ALA LEU TYR TYR LEU ILE SER SER PHE THR ASP SEQRES 10 S 541 GLN LEU PRO TRP THR SER CYS LYS ASN SER TRP ASN THR SEQRES 11 S 541 GLY ASN CYS THR ASN TYR PHE SER GLU ASP ASN ILE THR SEQRES 12 S 541 TRP THR LEU HIS SER THR SER PRO ALA GLU GLU PHE TYR SEQRES 13 S 541 THR ARG HIS VAL LEU GLN ILE HIS ARG SER LYS GLY LEU SEQRES 14 S 541 GLN ASP LEU GLY GLY ILE SER TRP GLN LEU ALA LEU CYS SEQRES 15 S 541 ILE MET LEU ILE PHE THR VAL ILE TYR PHE SER ILE TRP SEQRES 16 S 541 LYS GLY VAL LYS THR SER GLY LYS VAL VAL TRP VAL THR SEQRES 17 S 541 ALA THR PHE PRO TYR ILE ILE LEU SER VAL LEU LEU VAL SEQRES 18 S 541 ARG GLY ALA THR LEU PRO GLY ALA TRP ARG GLY VAL LEU SEQRES 19 S 541 PHE TYR LEU LYS PRO ASN TRP GLN LYS LEU LEU GLU THR SEQRES 20 S 541 GLY VAL TRP ILE ASP ALA ALA ALA GLN ILE PHE PHE SER SEQRES 21 S 541 LEU GLY PRO GLY PHE GLY VAL LEU LEU ALA PHE ALA SER SEQRES 22 S 541 TYR ASN LYS PHE ASN ASN ASN CYS TYR GLN ASP ALA LEU SEQRES 23 S 541 VAL THR SER VAL VAL ASN CYS MET THR SER PHE VAL SER SEQRES 24 S 541 GLY PHE VAL ILE PHE THR VAL LEU GLY TYR MET ALA GLU SEQRES 25 S 541 MET ARG ASN GLU ASP VAL SER GLU VAL ALA LYS ASP ALA SEQRES 26 S 541 GLY PRO SER LEU LEU PHE ILE THR TYR ALA GLU ALA ILE SEQRES 27 S 541 ALA ASN MET PRO ALA SER THR PHE PHE ALA ILE ILE PHE SEQRES 28 S 541 PHE LEU MET LEU ILE THR LEU GLY LEU ASP SER THR PHE SEQRES 29 S 541 ALA GLY LEU GLU GLY VAL ILE THR ALA VAL LEU ASP GLU SEQRES 30 S 541 PHE PRO HIS VAL TRP ALA LYS ARG ARG GLU ARG PHE VAL SEQRES 31 S 541 LEU ALA VAL VAL ILE THR CYS PHE PHE GLY SER LEU VAL SEQRES 32 S 541 THR LEU THR PHE GLY GLY ALA TYR VAL VAL LYS LEU LEU SEQRES 33 S 541 GLU GLU TYR ALA THR GLY PRO ALA VAL LEU THR VAL ALA SEQRES 34 S 541 LEU ILE GLU ALA VAL ALA VAL SER TRP PHE TYR GLY ILE SEQRES 35 S 541 THR GLN PHE CYS ARG ASP VAL LYS GLU MET LEU GLY PHE SEQRES 36 S 541 SER PRO GLY TRP PHE TRP ARG ILE CYS TRP VAL ALA ILE SEQRES 37 S 541 SER PRO LEU PHE LEU LEU PHE ILE ILE CYS SER PHE LEU SEQRES 38 S 541 MET SER PRO PRO GLN LEU ARG LEU PHE GLN TYR ASN TYR SEQRES 39 S 541 PRO TYR TRP SER ILE ILE LEU GLY TYR CYS ILE GLY THR SEQRES 40 S 541 SER SER PHE ILE CYS ILE PRO THR TYR ILE ALA TYR ARG SEQRES 41 S 541 LEU ILE ILE THR PRO GLY THR PHE LYS GLU ARG ILE ILE SEQRES 42 S 541 LYS SER ILE THR PRO GLU THR PRO HET KWC S 701 33 HETNAM KWC 1-[4-(4-FLUOROPHENYL)-1,3-THIAZOL-2-YL]PIPERAZINE FORMUL 4 KWC C13 H14 F N3 S HELIX 1 AA1 ARG C 47 SER C 51 5 5 HELIX 2 AA2 THR C 106 SER C 110 5 5 HELIX 3 AA3 GLU D 103 THR D 107 5 5 HELIX 4 AA4 LYS S 84 VAL S 97 1 14 HELIX 5 AA5 ASP S 98 ASN S 112 1 15 HELIX 6 AA6 GLY S 113 ALA S 116 5 4 HELIX 7 AA7 PHE S 117 PHE S 127 1 11 HELIX 8 AA8 GLY S 128 ARG S 144 1 17 HELIX 9 AA9 ILE S 148 LYS S 153 5 6 HELIX 10 AB1 CYS S 155 PHE S 158 5 4 HELIX 11 AB2 LYS S 159 SER S 190 1 32 HELIX 12 AB3 SER S 226 HIS S 235 1 10 HELIX 13 AB4 GLN S 238 SER S 242 5 5 HELIX 14 AB5 SER S 252 ILE S 270 1 19 HELIX 15 AB6 GLY S 273 ALA S 285 1 13 HELIX 16 AB7 THR S 286 LEU S 302 1 17 HELIX 17 AB8 GLY S 304 LYS S 314 1 11 HELIX 18 AB9 ASN S 316 LEU S 321 5 6 HELIX 19 AC1 GLU S 322 GLY S 338 1 17 HELIX 20 AC2 GLY S 342 TYR S 350 1 9 HELIX 21 AC3 ASN S 356 ARG S 390 1 35 HELIX 22 AC4 ASP S 393 LYS S 399 1 7 HELIX 23 AC5 ILE S 408 MET S 417 1 10 HELIX 24 AC6 ALA S 419 PHE S 454 1 36 HELIX 25 AC7 PHE S 454 ALA S 459 1 6 HELIX 26 AC8 ARG S 461 LEU S 478 1 18 HELIX 27 AC9 VAL S 479 THR S 482 5 4 HELIX 28 AD1 GLY S 484 ALA S 496 1 13 HELIX 29 AD2 GLY S 498 TRP S 514 1 17 HELIX 30 AD3 GLY S 517 GLY S 530 1 14 HELIX 31 AD4 GLY S 534 ALA S 543 1 10 HELIX 32 AD5 ALA S 543 MET S 558 1 16 HELIX 33 AD6 PRO S 571 ILE S 587 1 17 HELIX 34 AD7 ILE S 587 THR S 600 1 14 HELIX 35 AD8 THR S 603 THR S 613 1 11 SHEET 1 AA1 4 GLN C 24 GLN C 25 0 SHEET 2 AA1 4 VAL C 37 LYS C 42 -1 O LYS C 42 N GLN C 24 SHEET 3 AA1 4 THR C 97 LEU C 102 -1 O MET C 100 N ILE C 39 SHEET 4 AA1 4 ALA C 87 ASP C 92 -1 N ASP C 92 O THR C 97 SHEET 1 AA2 6 GLU C 29 VAL C 31 0 SHEET 2 AA2 6 THR C 134 VAL C 138 1 O THR C 137 N VAL C 31 SHEET 3 AA2 6 ALA C 111 ALA C 116 -1 N ALA C 111 O VAL C 136 SHEET 4 AA2 6 MET C 53 GLN C 58 -1 N GLN C 58 O VAL C 112 SHEET 5 AA2 6 LEU C 64 TYR C 71 -1 O GLU C 65 N LYS C 57 SHEET 6 AA2 6 ASP C 76 TYR C 79 -1 O LYS C 78 N ARG C 69 SHEET 1 AA3 4 LEU D 24 SER D 27 0 SHEET 2 AA3 4 ALA D 39 ALA D 45 -1 O SER D 42 N SER D 27 SHEET 3 AA3 4 TYR D 94 ILE D 99 -1 O PHE D 95 N CYS D 43 SHEET 4 AA3 4 PHE D 86 SER D 91 -1 N SER D 89 O SER D 96 SHEET 1 AA4 5 SER D 30 SER D 34 0 SHEET 2 AA4 5 THR D 126 LYS D 131 1 O LYS D 131 N VAL D 33 SHEET 3 AA4 5 ALA D 108 GLN D 114 -1 N TYR D 110 O THR D 126 SHEET 4 AA4 5 LEU D 57 GLN D 62 -1 N ASN D 58 O GLN D 113 SHEET 5 AA4 5 LYS D 69 ILE D 72 -1 O LYS D 69 N GLN D 61 SHEET 1 AA5 2 ARG S 564 LEU S 565 0 SHEET 2 AA5 2 TYR S 568 ASN S 569 -1 O TYR S 568 N LEU S 565 SSBOND 1 CYS C 41 CYS C 115 1555 1555 2.03 SSBOND 2 CYS S 200 CYS S 209 1555 1555 2.03 CISPEP 1 SER D 27 PRO D 28 0 -5.74 CISPEP 2 HIS D 100 PRO D 101 0 -2.61 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000